Michael K. Brawer, MD
Michael K. Brawer, MD is Vice President Medical Affairs, Urology, Myriad Genetics Laboratories. Dr. Brawer joins Myriad from GTx inc where he served as Executive Director Medical Affairs and Clinical Development (2009-2012). Prior to this he was Chief Medical Officer, Tokai Pharmaceuticals(2007-2009) From 2006–2007, Dr. Brawer was Interim Chief Medical Officer at Threshold Pharmaceuticals. In 1998, he was a founder of the Northwest Prostate Institute, a community hospital focused on clinical practice, community outreach, basic and clinical research and medical education, and served as Director until 2007. From 1986–1998, he held various academic appointments first at the University of Arizona and then at the University of Washington where he was Professor of Urology and Adjunct Professor of Pathology. Dr. Brawer has published more than 200 scientific papers, 10 books and 74 book chapters and is the recipient of 28 peer review competitive grants. In 1998, the American Urological Association bestowed upon him the Gold Cystoscope, given annually to a urologist distinguished by outstanding contributions to the profession within 10 years of completion of residency training. Dr. Brawer received his bachelor and medical degrees from the University of California, Los Angeles, where he also completed a fellowship in pathology, and completed his residency in urology at Stanford University Medical Center, where from 1985–1986 he was Chief Resident, Urology.